ECHS1 and colorectal carcinoma: The results indicated that ECHS1 overexpression significantly reduced mTORC downstream target protein levels in HCT116 and LoVo cells, suggesting that it may inhibit CRC proliferation via modulation of the mTORC pathway (Fig. 3B).